Allergy Immunotherapy Market

Published Aug 05, 2025

Length 154 Pages

SKU # CMI20399605

Description

Global allergy immunotherapy market is estimated to be valued at USD 2,740.6 Mn in 2025, and is expected to exhibit a CAGR of 9.8% during the forecast period (2025-2032). Allergy immunotherapy, commonly known as allergy shots or desensitization injections, refer to a medical treatment for certain allergies. It involves exposing people to gradually increasing amounts of allergen(s), with goal of decreasing the symptoms caused by the allergic response. The therapy is strictly administered under a physician's supervision. By administering controlled amounts of allergens, immunotherapy can lead to reduction in symptoms over time. It aims to reduce sensitivity to the identified allergens and lessen the patient's need for medication. The treatment usually spans 3-5 years depending on the individual's response and may provide long lasting relief from symptoms upon completion of therapy.

Market Dynamics

Global allergy immunotherapy market growth is primarily driven by rising prevalence of allergic diseases globally. Allergic rhinitis and asthma are among the most common observed chronic health issues. Growing environmental pollution and changing lifestyle factors have contributed to the allergy epidemic. Stringent regulatory guidelines for accurate diagnosis and management of allergic disorders further aid early adoption of immunotherapy. Development of sublingual and subcutaneous allergy vaccines with improved tolerability and faster onset of action can provide opportunities for the market growth. Adoption of recombinant antigen technologies and customized allergen extracts tailored to individual patients are key trends spurring R&D initiatives. However, high costs associated with prolonged therapy and lack of awareness in developing nations can hamper the market growth.

Key Features of the Study

This report provides an in-depth analysis of the global allergy immunotherapy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global allergy immunotherapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, Jubilant HollisterStier, Merck KGaA, Biomay AG, Hollister Allergy, Aravax Pty Ltd, Allovate, LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global allergy immunotherapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy immunotherapy market.

Market Segmentation

Treatment Type Insights (Revenue, USD Mn, 2020 - 2032)
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
10-30 MeV
30 -70 MeV
Allergy Type Insights (Revenue, USD Mn, 2020 - 2032)
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Stallergenes Greer
ALK-Abello A/S
Allergy Therapeutics
Allergopharma
HAL Allergy Group
Aimmune Therapeutics
DBV Technologies
Leti Pharma
Jubilant HollisterStier
Merck KGaA
Biomay AG
Hollister Allergy
Aravax Pty Ltd.
Allovate, LLC

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Treatment Type; Market Snapshot, By Allergy Type; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunities; Impact Analysis; Market Trends; Key Developments; Regulatory Scenario; Manufacturer Revenue; Acquisitions and Partnerships Scenario; Product Launches/Approvals; Funding and Investments; PEST Analysis; Porter’s Analysis
4. Global Allergy Immunotherapy Market, By Treatment Type, 2020 – 2032, (USD Mn): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Subcutaneous Immunotherapy (SCIT); Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Sublingual Immunotherapy (SLIT); Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); 10-30 MeV
30 -70 MeV
5. Global Allergy Immunotherapy Market, By Allergy Type, 2020 – 2032, (USD Mn): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Allergic Rhinitis; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Allergic Asthma; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Food Allergy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Venom Allergy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn)
6. Global Allergy Immunotherapy Market, By Distribution Channel, 2020 – 2032, (USD Mn): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Hospital Pharmacies; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Retail Pharmacies; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn); Online Pharmacies; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Mn)
7. Global Allergy Immunotherapy Market, By Region, 2020 – 2032, (USD Mn): Introduction; Market Share Analysis, By Region, 2025 and 2032 (%); Y-o-Y Growth Analysis, For Region, 2021–2032; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Mn); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Mn); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Mn); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Mn); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Mn); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Mn); North Africa; Central Africa; South Africa
8. Competitive Landscape: Company Profiles; Stallergenes Greer; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; ALK-Abello A/S; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Allergy Therapeutics; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Allergopharma; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; HAL Allergy Group; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Aimmune Therapeutics; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; DBV Technologies; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Leti Pharma; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Jubilant HollisterStier; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Merck KGaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Biomay AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Hollister Allergy; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Aravax Pty Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Allovate, LLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
9. Analyst Recommendations: Wheel of Fortune; Analyst View; Coherent Opportunity Map
10. References and Research Methodology: References; Research Methodology; About us and Sales Contact

Pricing

Currency Rates

Single User Email from Publisher $4,500
Site License Fulfilled by Publisher $7,000
Global Site License Email from Publisher $10,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now